TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans.

Smita S Chandran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.